EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Application of Lipidomics in Psychiatry: Plasma-Based Potential Biomarkers in Schizophrenia and Bipolar Disorder

Alana C Costa iD, Larissa B Riça iD, Martinus van de Bilt, Flávia S Zandonadi iD, Wagner F Gattaz, Leda L Talib iD, Alessandra Sussulini iD

Metabolites · 27.04.2023 · 13 (5) · 600

DOI: 10.3390/metabo13050600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 27.04.2023. Verfasst von Alana C Costa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuroscience (LIM-27), Department and Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo 05403903, Brazil. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, Fundação de Amparo à Pesquisa do Estado de São Paulo—FAPESP, Instituto Nacional de Biomarcadores em Neuropsiquiatria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we obtained a lipidomic profile of plasma samples from drug-naïve patients with schizophrenia (SZ) and bipolar disorder (BD) in comparison to healthy controls. The sample cohort consisted of 30 BD and 30 SZ patients and 30 control individuals. An untargeted lipidomics strategy using liquid chromatography coupled with high-resolution mass spectrometry was employed to obtain the lipid profiles. Data were preprocessed, then univariate (t-test) and multivariate (principal component analysis and orthogonal partial least squares discriminant analysis) statistical tools were applied to select differential lipids, which were putatively identified. Afterward, multivariate receiver operating characteristic tests were performed, and metabolic pathway networks were constructed, considering the differential lipids. Our results demonstrate alterations in distinct lipid pathways, especially in glycerophospholipids, sphingolipids and glycerolipids, between SZ and BD patients. The results obtained in this study may serve as a basis for differential diagnosis, which is crucial for effective treatment and improving the quality of life of patients with psychotic disorders.

Schlagwörter

Stichwörter der Autor:innen

biomarkersbipolar disorderlipidomicsplasmaschizophrenia

Autor:innen und Institutionen

  • Laboratory of Neuroscience (LIM-27), Department and Institute of Psychiatry, University of Sao Paulo Medical School, Sao Paulo 05403903, Brazil.
  • Instituto Nacional de Biomarcadores em Neuropsiquiatria (INBioN), Conselho Nacional de Desenvolvimento Científico e Tecnológico, Sao Paulo 05403903, Brazil.
  • Laboratory of Bioanalytics and Integrated Omics (LaBIOmics), Institute of Chemistry, University of Campinas (UNICAMP), Campinas 13083970, Brazil.
  • Instituto Nacional de Ciência e Tecnologia de Bioanalítica (INCTBio), Institute of Chemistry, University of Campinas (UNICAMP), Campinas 13083970, Brazil.

ORCID-Profile: Alana C Costa, Larissa B Riça, Flávia S Zandonadi, Leda L Talib, Alessandra Sussulini

Förderung

  • São Paulo Research Foundation
  • Fundação de Amparo à Pesquisa do Estado de São Paulo—FAPESP
  • Instituto Nacional de Biomarcadores em Neuropsiquiatria
  • Instituto Nacional de Ciência e Tecnologia de Bioanalítica
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico—CNPq
  • Associação Beneficente Alzira Denise Hertzog da Silva (ABADHS)

Zitieren

APA

Costa, A. C., Riça, L. B., van de Bilt, M., Zandonadi, F. S., Gattaz, W. F., Talib, L. L., & Sussulini, A. (2023). Application of Lipidomics in Psychiatry: Plasma-Based Potential Biomarkers in Schizophrenia and Bipolar Disorder. Metabolites, 13(5), 600. https://doi.org/10.3390/metabo13050600

Vancouver

Costa AC, Riça LB, van de Bilt M, Zandonadi FS, Gattaz WF, Talib LL, et al. Application of Lipidomics in Psychiatry: Plasma-Based Potential Biomarkers in Schizophrenia and Bipolar Disorder. Metabolites. 2023;13(5):600. doi:10.3390/metabo13050600

BibTeX
@article{Costa2023,
  author = {Costa, Alana C and Riça, Larissa B and van de Bilt, Martinus and Zandonadi, Flávia S and Gattaz, Wagner F and Talib, Leda L and Sussulini, Alessandra},
  title = {Application of Lipidomics in Psychiatry: Plasma-Based Potential Biomarkers in Schizophrenia and Bipolar Disorder},
  journal = {Metabolites},
  year = {2023},
  volume = {13},
  number = {5},
  pages = {600},
  doi = {10.3390/metabo13050600}
}
Kostenlos starten →